Michael S Perry insider trades
Open-market stock purchases and sales by Michael S Perry, Director at Arrowhead Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 5, 2010.
Companies traded
- ARWR Arrowhead Pharmaceuticals, Inc: 10 sales, last Aug 18, 2026
- RCEL AVITA Medical, Inc: 9 sales, last Nov 21, 2022
- ARMP Armata Pharmaceuticals, Inc: other filings, last May 22, 2019
- APHB AmpliPhi Biosciences Corp: 3 buys, last Mar 22, 2018
- PARD Poniard Pharmaceuticals, Inc: 3 sales, last Mar 27, 2012
- TGEN.PK Targeted Genetics Corp /wa/: other filings, last May 27, 2010